Show simple item record

dc.contributor.editorDhein, Kelleen_US
dc.creatorMeek, Caroline
dc.date2019-08-26en_US
dc.date.accessioned2019-08-26T18:37:24Z
dc.date.available2019-08-26T18:37:24Z
dc.date.created2019-08-26
dc.identifier.urihttps://hpsrepository.asu.edu/handle/10776/13122
dc.description.abstractIn 1993, the NIH published the Revitalization Act that established guidelines for minorities’ and women’s participation in clinical research. Before the 1990s, investigators largely excluded women from their research based on the 1979 guidance from the US Food and Drug Administration, or FDA. The FDA urged investigators to exclude any woman who was or could become, pregnant to protect the woman and any developing fetuses from harm. Between 1979 and 1993, several other US governmental agencies urged investigators to increase the number of women in their clinical research to improve the state of women’s healthcare. After Congress passed the National Institutes of Health Revitalization Act, hereafter Revitalization Act of 1993, investigators who used NIH funds for clinical research were required to include both women and minorities in their clinical research. The Revitalization Act established the Office of Research on Women’s Health headquartered in Washington, DC and required investigators to include women in their clinical research, thus improving the quality of women’s health research.en_US
dc.format.mediumtext/xhtmlen_US
dc.language.isoen_USen_US
dc.language.isoen_US
dc.publisherArizona State University. School of Life Sciences. Center for Biology and Society. Embryo Project Encyclopedia.en_US
dc.relation.ispartofEmbryo Project Encyclopediaen_US
dc.rightsCopyright Arizona Board of Regentsen_US
dc.subjectLawen_US
dc.subject.lcshNIH publicationen_US
dc.subject.lcshdrug lawen_US
dc.subject.lcshLegislation, Drugen_US
dc.subject.lcshUnited States. National Institutes of Health Revitalization Act of 1993en_US
dc.subject.lcshNational Institutes of Health (U.S.). Clinical Centeren_US
dc.subject.lcshNational Institutes of Health (U.S.). Office of Human Subjects Researchen_US
dc.subject.lcshClinical medicine--Researchen_US
dc.subject.lcshMedical research personnelen_US
dc.subject.lcshDecision (United States. Government Accountability Office)en_US
dc.subject.lcshUnited States. Government Accountability Officeen_US
dc.subject.lcshNational Institutes of Health (U.S.). Office of Extramural Researchen_US
dc.subject.lcshNational Institutes of Health (U.S.). Office for Protection from Research Risksen_US
dc.titleTitle 1, Subtitle B, Parts I, II, and III of the “National Institutes of Health Revitalization Act of 1993” (1993)en_US
dc.typeArticleen_US
dc.typeTexten_US
dc.rights.licenseLicensed as Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported (CC BY-NC-SA 3.0) http://creativecommons.org/licenses/by-nc-sa/3.0/en_US
dc.subject.embryoLegalen_US
dc.subject.tagNational Institutes of Healthen_US
dc.subject.tagClinical Researchen_US
dc.description.typeArticlesen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record